1
TITLE: Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV-infected, ARV-naive patients  Full Text
AUTHORS: Daniel Podzamczer; Jhon F Fredy Rojas; Isabel Neves; Elena Ferrer; Josep M Llibre; Manuel Leal; Miguel Gorgolas; Ma J Jose Crusells; Josep Ma Gatell; Ricardo C Correia Abreu; Jordi Curto; Pere Domingo; Ma P Pilar Barrufet; Nerea Rozas;
PUBLISHED: 2014, SOURCE: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, VOLUME: 17, ISSUE: 4(Suppl 3)
INDEXED IN: WOS CrossRef
2
TITLE: Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial
AUTHORS: Vicente Soriano; Keikawus Arasteh; Horacio Migrone; Thomas Lutz; Milos Opravil; Jaime Andrade Villanueva; Francisco Antunes ; Giovanni Di Perri; Daniel Podzamczer; Steve Taylor; Pere Domingo; Holger Gellermann; Lothar de Rossi;
PUBLISHED: 2011, SOURCE: ANTIVIRAL THERAPY, VOLUME: 16, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
3
TITLE: Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, HIV-1-Infected Adults: 48-Week Results From the ASSERT Study
AUTHORS: Frank A Post; Graeme J Moyle; Hans Juergen Stellbrink; Pere Domingo; Daniel Podzamczer; Martin Fisher; Anthony G Norden; Matthias Cavassini; Armin Rieger; Marie Aude Khuong Josses; Teresa Branco; Helen C Pearce; Naomi Givens; Cindy Vavro; Michael L Lim;
PUBLISHED: 2010, SOURCE: 12th European AIDS Conference/European-AIDS-Clinical-Society (EACS) in JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, VOLUME: 55, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef